Clinical Trial Update: A New Track Ablation Device for Liver Biopsy: A Feasibility Study [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 feasibility study is evaluating a new track ablation device for liver biopsy, sponsored by Samsung Medical Center, for liver neoplasms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Neoplasms

Drugs mentioned

• Track Ablation Device for Liver Biopsy

Snippet

Sponsor: Samsung Medical Center | Conditions: Liver Neoplasms | Phase 1, Phase 2 | Status: UNKNOWN